Updates and news related to prostate cancer:
Late luteinizing hormone-released hormones (LHRH) injections cause spike in testosterone levels in prostate cancer
Read this OncLive article by Brittany Cote.
Data confirm decades-old hypothesis that metastatic disease hijacks tissue-specific developmental programs
Biomarker-driven monotherapy enters non-metastatic castration-resistant prostate cancer (nmCRPC) paradigm
Olaparib is now available for patients with nmCRPC whose tumor harbors certain mutations.
Read this article in Renal & Urology News.
UCLA researches find cryotherapy as an effective treatment for men with intermediate-risk prostate cancer
UCLA Health news release
Shorter radiation treatment regimens are evidence-based practices that are similarly effective and safe.
Patient enrollment now underway in Phase 3 SPOTLIGHT as well as LIGHTHOUSE clinical trials in prostate cancer
The use of genetic information to attack cancers: Prostate Health Education Network video
Vanderbilt researchers have identified ancestral fragments of DNA associated with hereditary prostate cancer.
The protein makes tumors more aggressive, helping them migrate to other organs.